Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.

Details

Language :

English

ISSN :

10780998

Volume :

28

Issue :

1

Database :

Complementary Index

Journal :

Inflammatory Bowel Diseases

Publication Type :

Academic Journal

Accession number :

154595893

Full Text :

https://doi.org/10.1093/ibd/izab027